Tag: Cancer: Laryngeal
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
Vaccination found to be safe and induces polyclonal immune responses against vaccine targets
Decrease in Head and Neck Cancer Incidence Seen During Pandemic
Localized cancer incidence decreased the most among men, Hispanic patients, individuals with larynx cancer
Community Cancer Centers Treating More HPV-Related Head, Neck Cancer
More patients being treated nonsurgically tied to worse survival
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
Skeletal muscle index-derived sarcopenia associated with worse overall survival, longer feeding tube duration
Overweight Tied to Better Head, Neck Cancer Outcomes After Chemoradiotherapy
Benefits seen for complete metabolic response after chemoradiotherapy, survival, and locoregional failure
Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
Black race linked to increased risk of uncontrolled risk factors; higher rates for patients with larynx cancer
Model Can Predict Postoperative RT Delay in Head & Neck Cancer
Model incorporating individual-level factors with health literacy and community-level factors most predictive of postoperative radiation therapy delay
Quitting Smoking Tied to Better Survival in Head, Neck Squamous Cell Carcinoma
Greatest benefit seen for former smokers who quit >10 years before diagnosis
Outcomes Worse for Black Patients With Head, Neck Cancer in Clinical Trials
Outcomes worse for Black versus White patients enrolled in clinical trials that minimize access to care, socioeconomic status confounders
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
Findings seen in studies involving patients receiving chemoradiotherapy for nonmetastatic squamous cell carcinoma of head and neck
